Company: APM
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001213900-25-037669
Chunk: 226

Company: Aptorum Group Ltd
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 226
---
 APTUS Holdings
Limited and STRIKER ASIA OPPORTUNITIES FUND CORPORATION, is a company incorporated on September 13, 2010 under the laws of the Cayman
Islands with limited liability.

The Company researches and develops life science
and biopharmaceutical products within its wholly-owned subsidiary, Aptorum Therapeutics Limited, formerly known as APTUS Therapeutics
Limited (“ Aptorum Therapeutics”) and its indirect subsidiary companies.

Below summarizes the list of the major subsidiaries consolidated as
of December 31, 2024:

  Name                                       Incorporation       Ownership      Place of            Principle activities                                                             
                                             date                               incorporation                                                                                        
  Aptorum Therapeutics Limited (“ ATL”)      June 30, 2016             100      Cayman Islands      Research and development of life science and biopharmaceutical products          
  APTUS MANAGEMENT LIMITED                   May 16, 2017              100      Hong Kong           Provision of management services to its holding company and fellow subsidiaries  
  Paths Innovations Limited                  April 15, 2019            100      Cayman Islands      Investment holding company                                                       
  Paths Diagnostics Pte. Limited             June 5, 2019               75      Singapore           Research and development of life science and biopharmaceutical products          
  Acticule Life Sciences Limited             June 30, 2017              80      Cayman Islands      Research and development of life science and biopharmaceutical products          
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

F-7

APTORUM GROUP LIMITED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Stated in U. S. Dollars)

2. GOING CONCERN

The Group reported a net loss of $4,157,737and
net operating cash outflow of $1,189,734for the year ended December 31, 2024. In addition, the Group had an accumulated deficit of $72,429,528as of December 31, 2024. On January 2, 2025, the Group entered into a certain securities purchase agreement with certain non-affiliated
institutional investors pursuant to which the Group sold1,535,000Class A Ordinary Shares of the Group, par value $0.00001per share
at a per share price of $2.00in a registered direct offering, for gross proceeds of $